Related Experiment Video
Updated: Jan 20, 2026
Expected Income, Expected Utility, and Risk Aversion II
Published on: March 26, 2025
What are the realistic expectations of tocolytics?
1Department of Obstetrics and Gynaecology, Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada.
Current tocolytic therapies for preterm birth show limited effectiveness and potential harm. Evidence suggests these treatments do not improve neonatal outcomes, highlighting the need for safer, more effective alternatives in managing premature delivery.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Public Health
Background:
- Preterm birth is a leading global cause of infant mortality and long-term disability.
- Effective tocolytic therapy is crucial for delaying delivery to administer antenatal corticosteroids and facilitate transfer to specialized care centers.
- Current tocolytic agents in Canada demonstrate poor efficacy and significant maternal/fetal side effects.
Purpose of the Study:
- To evaluate the efficacy and safety of currently available tocolytic therapies for preterm birth.
- To assess the impact of tocolytic use on neonatal outcomes and maternal health.
- To inform clinical practice guidelines based on robust scientific evidence.
Main Methods:
- Review of evidence, emphasizing randomized clinical trials, as per the Canadian Tocolysis Consensus Conference.
- Assessment of existing tocolytic treatments including ritodrine, indomethacin, calcium antagonists, and magnesium sulfate.
- Analysis of data regarding effectiveness in delaying delivery and improving neonatal outcomes.
Main Results:
- Little evidence supports the use of currently available tocolytics.
- Tocolytic therapy has not been shown to improve perinatal outcomes.
- Existing tocolytics are associated with detrimental maternal effects and questionable efficacy.
Conclusions:
- Current tocolytic therapies offer questionable benefits and carry potential risks, outweighing their use.
- There is a critical need for novel tocolytic agents with demonstrated efficacy in improving neonatal outcomes.
- Development of effective tocolytics would significantly reduce neonatal morbidity, mortality, and associated healthcare costs.
Related Concept Videos
Uncertainty and Expected Value
Expected Income, Expected Utility, and Risk Aversion II
Expected Income, Expected Utility, and Risk Aversion I
Expected Value
Determination of Expected Frequency
Expected Return
Expected returns help investors make informed decisions by providing insights into potential future performance. However,...